test

Michael Elgort

@Parkman Healthcare Partners Llc

Latest period2024 - Q3ReportedManaged Assets$783.443MTotal holdings93
Assets growth rate4.94%Assets growth rate (2-Q avg)-1.72%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Parkman Healthcare Partners Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 93 positions.

Assets under management

The assets under management (AUM) of Parkman Healthcare Partners Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 783.443M in assets, with a quarterly growth rate of 4.94% and a 2-quarter average growth rate of -1.72%. The portfolio is managed by Michael Elgort, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
BCYCBicycle Therapeutics Plc
Recent Activity
Decreased -16.75%
1.29%
$10.079M
445,396 shares@ $22.63 avg price
NRIXNurix Therapeutics Inc
Recent Activity
Decreased -7.52%
1.26%
$9.864M
438,971 shares@ $22.47 avg price
SNDXSyndax Pharmaceuticals Inc
Recent Activity
Decreased -15.38%
1.25%
$9.784M
508,283 shares@ $19.26 avg price
QGENQiagen Nv
Recent Activity
Decreased -10.03%
1.23%
$9.605M
210,769 shares@ $45.57 avg price
RXSTRxsight Inc
Recent Activity
Decreased -37.88%
1.17%
$9.111M
184,320 shares@ $49.44 avg price
APLTApplied Therapeutics Inc
Recent Activity
Decreased -20.98%
0.99%
$7.712M
907,294 shares@ $8.5 avg price
XENEXenon Pharmaceuticals Inc
Recent Activity
Decreased -8.42%
0.97%
$7.546M
191,658 shares@ $39.37 avg price
ICLRIcon Plc
Recent Activity
Decreased -29.26%
0.97%
$7.531M
26,212 shares@ $287.32 avg price
STROSutro Biopharma Inc
Recent Activity
Decreased -4.27%
0.76%
$5.938M
1.716M shares@ $3.47 avg price
ACLXArcellx Inc
Recent Activity
Decreased -57.6%
0.71%
$5.553M
66,492 shares@ $83.52 avg price